#240 Can Competition and Quality Coincide? Analyzing a Systematic Competition Law Approach to Healthcare and Quality Concerns
The role of antitrust in health care is a common topic in the antitrust world. […]
#239 No More Clouds on the Horizon? The UK CMA’s Investigation Into Microsoft’s Acquisition of Activision Blizzard
Microsoft’s proposed acquisition of Activision Blizzard was controversially blocked in its original form by the […]
#238 Who Is Fiona Schaeffer? Meet the New Chair of the ABA Antitrust Law Section
Fiona Schaeffer, a prominent antitrust lawyer, has taken on the big job of leading the […]
#237 Should We Bank on Changes? A Conversation About Bank Merger Policy
Bank failures in 2023 led to renewed interest in bank consolidation and debate over the […]
#236 What Is PE Anyway? All the Questions You Were Afraid To Ask About Private Equity
Private equity has been in the hot seat at the Federal Trade Commission and the […]
#235 Win, Lose, or Draw? A Decade of Pharma Antitrust Since FTC vs. Actavis
Ten years ago, the U.S. Supreme Court issued its 5-3 decision in FTC v. Actavis, […]
#234 What About Small Tech? Democratizing Employment Data
Employment data is a critical component of the financial ecosystem—it’s required documentation if you want […]
#233 What Are the Thoughts Behind the Changes? Draft DOJ-FTC Merger Guidelines Explained by DOJ DAAGs
On July 19, 2023, the U.S. Department of Justice’s Antitrust Division and the Federal Trade […]
#232 Never a Dull Moment In Antitrust? Conversation With Judge Douglas Ginsburg
Antitrust cases are often complex and technical, which invites suspicion that such cases should be […]
#231 What’s Happening in MENA? Trends and Developments in Middle East and Egyptian Antitrust
Merger control and antitrust enforcement continues to expand around the world. Is MENA ahead of […]